Technical Analysis for RAPT - RAPT Therapeutics, Inc.

Grade Last Price % Change Price Change
D 2.23 5.19% 0.11
RAPT closed up 5.19 percent on Friday, November 1, 2024, on 1.23 times normal volume.
Earnings due: Nov 11
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Calm After Storm Range Contraction 5.19%
Inside Day Range Contraction 5.19%
Wide Bands Range Expansion 5.19%
Upper Bollinger Band Touch Strength 5.19%
MACD Bullish Centerline Cross Bullish 1.36%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 22 hours ago
2x Volume Pace about 23 hours ago
Up 10% about 23 hours ago
Up 1 ATR about 23 hours ago
1.5x Volume Pace about 23 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

RAPT Therapeutics, Inc. Description

RAPT Therapeutics, Inc., a clinical stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. The company develops small molecules that are designed to modulate the critical immune responses underlying these diseases. Its lead oncology drug candidate is FLX475 for the treatment of a range of tumors; and RPT193, a CCR4 antagonist for allergic inflammatory disease. The company is also pursuing a range of targets, including general control nonderepressible and hematopoietic progenitor kinase for the treatment of cancer. RAPT Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California. RAPT Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Immunology Pharmacy Treatment Of Cancer Tumor Inflammatory Diseases Specialty Drugs Small Molecule Therapies Immune Response

Is RAPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.35
52 Week Low 1.64
Average Volume 259,625
200-Day Moving Average 6.71
50-Day Moving Average 1.94
20-Day Moving Average 1.87
10-Day Moving Average 1.93
Average True Range 0.20
RSI (14) 60.94
ADX 23.87
+DI 31.56
-DI 8.59
Chandelier Exit (Long, 3 ATRs) 1.89
Chandelier Exit (Short, 3 ATRs) 2.25
Upper Bollinger Bands 2.19
Lower Bollinger Band 1.55
Percent B (%b) 1.06
BandWidth 34.32
MACD Line 0.04
MACD Signal Line -0.02
MACD Histogram 0.0619
Fundamentals Value
Market Cap 76.7 Million
Num Shares 34.4 Million
EPS -2.89
Price-to-Earnings (P/E) Ratio -0.77
Price-to-Sales 266.16
Price-to-Book 5.21
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.60
Resistance 3 (R3) 2.61 2.50 2.54
Resistance 2 (R2) 2.50 2.40 2.49 2.52
Resistance 1 (R1) 2.36 2.35 2.43 2.35 2.50
Pivot Point 2.25 2.25 2.29 2.25 2.25
Support 1 (S1) 2.12 2.16 2.19 2.11 1.96
Support 2 (S2) 2.01 2.10 2.00 1.94
Support 3 (S3) 1.87 2.01 1.92
Support 4 (S4) 1.86